Gala Pharmaceutical Inc. Other Income and Expense
Gala Pharmaceutical Inc. reported Other Income and Expense of -$1.65 million for the 3-month period ending 2019-05-31, per its 10-Q filed 2019-07-23.
Discontinued › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2019-07-23
- Gala Pharmaceutical Inc. nonoperating income (expense) for the quarter ending 2019-05-31 was -$1.65M.
- Gala Pharmaceutical Inc. nonoperating income (expense) for the quarter ending 2019-02-28 was -$368.72K.
- Gala Pharmaceutical Inc. nonoperating income (expense) for the quarter ending 2018-11-30 was $269.16K.
- Gala Pharmaceutical Inc. nonoperating income (expense) for the quarter ending 2018-08-31 was -$408.10K.
- Gala Pharmaceutical Inc. nonoperating income (expense) for fiscal 2018 was -$189.39K.
- Gala Pharmaceutical Inc. nonoperating income (expense) for fiscal 2017 was -$1.18M.
- Gala Pharmaceutical Inc. nonoperating income (expense) for fiscal 2016 was -$1.74K.
- Gala Pharmaceutical Inc. nonoperating income (expense) for fiscal 2015 was -$64.19K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2019-05-31 | -$1.65M 10-Q · filed 2019-07-23 | -$2.02M 10-Q · filed 2019-07-23 | -$1.75M derived: sum of 3 quarters · filed 2019-07-23 | -$2.16M derived: sum of 4 quarters · filed 2019-07-23 |
| 2019-02-28 | -$368.72K 10-Q · filed 2019-04-30 | -$99.56K derived: sum of 2 quarters · filed 2019-04-30 | -$507.66K derived: sum of 3 quarters · filed 2019-04-30 | -$523.10K derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-11-30 | $269.16K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-15 | -$138.94K derived: sum of 2 quarters · filed 2019-04-15 | -$154.38K derived: sum of 3 quarters · filed 2019-07-23 | -$189.39K 10-K · filed 2019-04-15 |
| 2018-08-31 | -$408.10K 10-Q · filed 2018-10-26 | -$423.54K derived: sum of 2 quarters · filed 2019-07-23 | -$458.56K 10-Q · filed 2018-10-26 | -$959.60K derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-05-31 | -$15.44K 10-Q · filed 2019-07-23 | -$50.45K 10-Q · filed 2019-07-23 | -$551.50K derived: sum of 3 quarters · filed 2019-07-23 | -$959.89K derived: sum of 4 quarters · filed 2019-07-23 |
| 2018-02-28 | -$35.01K 10-Q · filed 2019-04-30 | -$536.06K derived: sum of 2 quarters · filed 2019-04-30 | -$944.45K derived: sum of 3 quarters · filed 2019-04-30 | -$1.22M derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-11-30 | -$501.05K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-15 | -$909.43K derived: sum of 2 quarters · filed 2019-04-15 | -$1.18M derived: sum of 3 quarters · filed 2019-04-15 | -$1.18M 10-K · filed 2019-04-15 |
| 2017-08-31 | -$408.38K 10-Q · filed 2018-10-26 | -$681.85K derived: sum of 2 quarters · filed 2018-10-26 | -$682.52K 10-Q · filed 2018-10-26 | |
| 2017-05-31 | -$273.47K 10-Q · filed 2018-08-01 | -$274.14K 10-Q · filed 2018-08-01 | ||
| 2017-02-28 | -$673.00 10-Q · filed 2018-05-08 | |||
| 2016-11-30 | -$1.74K 10-K · filed 2018-04-06 | |||
| 2016-02-29 | -$316.00 10-Q · filed 2016-05-10 | |||
| 2015-11-30 | -$64.19K 10-K/A · filed 2017-03-23 | |||
| 2015-02-28 | $116.00 10-Q · filed 2016-05-10 | |||
| 2014-11-30 | -$189.97K 10-K · filed 2016-03-22 |